Cancer Cytopathology

Official page of Cancer Cytopathology, a journal of the American Cancer Society. Editor-in-Chief: William C. Faquin, MD, PhD (@bfaquin) #CytoPath

[Cancer Cytopathology @CancerCytopath]

👉#OpenAccess! | Choice of fixative affects programmed death-ligand 1 expression in cell blocks from pleural effusions with metastatic pulmonary adenocarcinoma

https://t.co/jMunyqF3GP

#CytoPath @IvanaKholova @Mansour_cytopat

[Cancer Cytopathology @CancerCytopath]

#OpenAccess from @ClevelandClinic investigators | Atypical squamous cells in urine cytology are associated with a significant risk of high-grade malignancy.

https://t.co/WJDu4O8aEI

#CytoPath @CCFPathRes @CleClinicMD

[Cancer Cytopathology @CancerCytopath]

📣New and #OpenAccess Review! | Implementation and impact of primary HPV testing in cervical cancer screening: Historical perspectives and institutional experience at a large academic medical center

https://t.co/GHlIXGHEvm

#CytoPath CC: @MichiyaNishino @IvanaKholova

[Cancer Cytopathology @CancerCytopath]

🎥 In a new #CytoVideo, Dr. Sarah Wu (@BrighamWomens) discusses her recent study that demonstrates how the use of a TRBC1/CD3 dual stain can be used to identify monoclonal populations of T cells in cytology specimens.

Read Dr. Wu's article: https://t.co/CFkZvNcjA9

#CytoPath

[Cancer Cytopathology @CancerCytopath]

DICER1 mutations in Bethesda category II, III, and IV thyroid nodules: A mutually exclusive relationship with BRAFV600E mutation

https://t.co/l5wiC5rVd4

#CytoPath

[Cancer Cytopathology @CancerCytopath]

🔬 Diagnostic utility of p53, SMAD4, and the novel biomarker PON2 in FNA of pancreatic ductal adenocarcinoma

https://t.co/goRc99zmxZ

#CytoPath @gcai1978 @yalepathology

[Cancer Cytopathology @CancerCytopath]

#OpenAccess | Evaluation of 9 antibodies in a set of lung #adenocarcinoma cases, each with 4 matched effusion cell blocks, fixed in formalin, PreservCyt®, CytoLyt® and CytoRich™ Red, respectively.

https://t.co/X2UdSZG85l

@Mansour_cytopat

#CytoPath

[Cancer Cytopathology @CancerCytopath]

🔬 Practice Essentials! Diagnostic approach to FNA biopsy of cystic lesions of the head and neck

https://t.co/QC1BsftxfY

#CytoPath @aakasharmand @AndrianusStefen

[Cancer Cytopathology @CancerCytopath]

#OpenAccess: FNA and effusion cytology of thoracic SMARCA4–deficient undifferentiated tumor and SMARCA4-deficient NSCLC: A multi-institutional experience with 27 patients

https://t.co/Tqu0XuvXYM

#CytoPath @PathPro @SatturwarSwati @smlungpathguy @ZallesNicole

[Cancer Cytopathology @CancerCytopath]

Free access⚡Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases

https://t.co/R7XzPSHnHi

@bfaquin @aakasharmand #CytoPath

[Cancer Cytopathology @CancerCytopath]

#OpenAccess | The role of #cytopathology in the molecular and computational era: The perspective of young #pathologists. New avenues for collaboration, education, and remote consultation are opening.

https://t.co/qlAb0KmiLV

#CytoPath @ACaputoMD @VLimperioMD @PasqualePisapia

[Cancer Cytopathology @CancerCytopath]

👌New! Keratin 17 ICC in urine cytology for urothelial carcinoma detection: Diagnostic performance and interobserver agreement in a prospective real-world cohort

https://t.co/gen0aMeA6K

#CytoPath CC: @IvanaKholova

[Cancer Cytopathology @CancerCytopath]

💥 Neutrophil-calibrated atypical squamous cells in ThinPrep urine cytology for detecting squamous differentiation in urothelial carcinoma

https://t.co/HIafiLDNgV

#CytoPath

[Cancer Cytopathology @CancerCytopath]

🔬#OpenAccess! Investigators from Japan conclude that the modified @MilanSystem as well as the @WHO system may be a useful cytopathologic classification tool for both bone and soft tissue lesions.

https://t.co/mJ2FAIWkLd

CC: @MichiyaNishino
#CytoPath

[Cancer Cytopathology @CancerCytopath]

Combined p53 and SMAD4 immunostaining could help improve FNA diagnosis of PDACs, particularly in challenging cases

https://t.co/goRc99zmxZ

#CytoPath @gcai1978 @yalepathology

[Cancer Cytopathology @CancerCytopath]

Our latest #CytoSource covers new progress in addressing cancer pain. Recent studies have offered revealing insights into predisposing, precipitating, and perpetuating factors as well as underlying mechanisms and potential interventions.

https://t.co/2symzzhynr

@bfaquin

[Cancer Cytopathology @CancerCytopath]

✨Free access! Cytologic features of differentiated high-grade thyroid carcinoma: A multi-institutional study of 40 cases

https://t.co/ugYMaCu980

@VandaTorousMD @PathPro #CytoPath

[Cancer Cytopathology @CancerCytopath]

🆕🔬 New and #OpenAccess! Molecular profiling of breast cancer pleural effusions using cytology specimens: Impact of sample source and cytological features on next-generation sequencing performance

https://t.co/pAq68H6IWQ

#CytoPath #BreastPath @cwru

[Cancer Cytopathology @CancerCytopath]

New! Accurate focal-plane selection is crucial for artificial intelligence assessment of three-dimensional urine cytology specimens for bladder cancer screening and surveillance

https://t.co/aBcZ0W2m11

#CytoPath @cjvand @YosephSayegh @JHUPath

[Cancer Cytopathology @CancerCytopath]

Free Access for Friday! Intraoperative peritoneal cytology for cervical gastric-type adenocarcinoma: Cytopathology and clinical impact

🔗: https://t.co/rzTy3W2VX6

#CytoPath #GynPath